CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Debt-to-Equity : 0.06 (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Debt-to-Equity?

CTT Pharmaceutical Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2018 was $0.00 Mil. CTT Pharmaceutical Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2018 was $0.04 Mil. CTT Pharmaceutical Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2018 was $0.66 Mil. CTT Pharmaceutical Holdings's debt to equity for the quarter that ended in Jun. 2018 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CTT Pharmaceutical Holdings's Debt-to-Equity or its related term are showing as below:

CTTH's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

CTT Pharmaceutical Holdings Debt-to-Equity Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings Debt-to-Equity Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Debt-to-Equity

Get a 7-Day Free Trial

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
Debt-to-Equity	Get a 7-Day Free Trial															-	N/A	N/A	-	0.06

Competitive Comparison of CTT Pharmaceutical Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTT Pharmaceutical Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's Debt-to-Equity falls into.

CTT Pharmaceutical Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CTT Pharmaceutical Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2015 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.335
	=	0.00

CTT Pharmaceutical Holdings's Debt to Equity Ratio for the quarter that ended in Jun. 2018 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.04)	/	0.659
	=	0.06

CTT Pharmaceutical Holdings (OTCPK:CTTH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

CTT Pharmaceutical Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives